Following the launch of the MULTIPLY project (IPTi implementation study) in Sierra Leone in November 2021, the first child received the first of six sulfadoxine-pyrimethamine (SP) doses of Intermittent Preventive Treatment of malaria in infants (IPTi-SP) in February 2022. Furthermore, MULTIPLY was officially launched in Togo on 21 January 2022, where the project has already reached 100% recruitment in the baseline household survey, 75% recruitment in the baseline SP resistance study and 25% recruitment in the standard of care cohort study. Togo and Mozambique will soon be the next countries in sub-Saharan Africa to implement the IPTi-SP intervention to reduce illness and death in children from Plasmodium infection through the MULTIPLY study.
